EMA finds possible link between AstraZeneca vaccine and rare blood clots, UK regulator offers under 30s alternative vaccines

The European Medicines Agency says it has found a possible link between AstraZeneca’s COVID-19 vaccine and rare blood clotting issues in adults who had received the shot, after it had taken into consideration all available evidence.

It comes as the UK’s vaccine advisory board, the Joint Committee on Vaccines and Immunisation (JCVI), said all those under the age of 30 will be offered alternative vaccines, including Pfizer’s and Moderna’s, due to a small number of blood clots linked to the AstraZeneca vaccine.

The JCVI said there had been 79 reported cases of blood clots in the UK after more than 20 million doses of the AstraZeneca vaccine, 19 of whom have died.

Both the EMA and JCVI reiterated that the advantages of the AstraZeneca vaccine…

Click here to view the original article.

The post EMA finds possible link between AstraZeneca vaccine and rare blood clots, UK regulator offers under 30s alternative vaccines appeared first on Mackay Online News.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *